Skip to main content

Advertisement

Log in

Adhesion of carcinoma cells to rat hepatocytes and rat fibronectin is inhibited by the OPAR monoclonal antibody, which is directed against a rat liver-specific carbohydrate epitope

  • Research Papers
  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

The OPAR mouse monoclonal antibody (mAb) directed against rat hepatocytes was previously shown to inhibit adhesion of TA3/Ha mammary carcinoma cells to hepatocytes. The antigen is abundantly present at the surface of hepatocytes beneath the endothelium of liver capillaries where we have observed invasion of carcinoma cells to occur. The OPAR mAb reacted with three major bands on a Western blot of liver plasma membrane proteins. The same proteins were also seen upon immunoprecipitation from iodinated liver plasma membrane proteins. We have isolated OPAR antigens by lectin wheat germ agglutinin (WGA) and OPAR affinity chromatography. Amino acid sequence analysis revealed that two of the bands were α1-macroglobulin and C4-binding protein, which are serum components produced by hepatocytes. The presence of the epitope on distinct proteins and our previous observation that it can be detected in the Golgi apparatus but not in the endoplasmic reticulum, suggested that OPAR reacts with a liver-specific glycoconjugate. Loss of OPAR reactivity after neuraminidase and N-glycosidase F treatment showed that the epitope contains sialic acid residues on N-linked sugar moieties. OPAR also reacted with rat fibronectin, and inhibited adhesion of TA3/St cells to fibronectin. This explains the inhibition by the OPAR mAb of TA3/St cell adhesion to hepatocytes, which we have shown to be due mainly to interaction with hepatocyte surface-associated fibronectin. However, adhesion of the related TA3/Ha cells to hepatocytes, which is mediated by the α6P4 integrin, and does not involve binding to fibronectin, is also inhibited. This suggests that α6β4 on liver-metastasizing carcinoma cells binds to an OPAR epitope-carrying glycoprotein produced by hepatocytes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Roos E, 1991, Adhesion molecules in lymphoma metastasis. [Review]. Cancer Metastasis Rev, 10, 33–48.

    Google Scholar 

  2. Roos E, Dingemans KP, Van de Pavert IV and Van den Bergh-Weerman MA, 1978, Mammary carcinoma cells in the mouse liver: infiltration of liver tissue and interaction with Kupffer cells. Br J Cancer, 38, 88–99.

    Google Scholar 

  3. Kemperman H, Wijnands Y, de Rijk D and Roos E, 1993, The integrin alpha 6 beta 4 on TA3/Ha mammary carcinoma cells is involved in adhesion to hepatocytes. Cancer Res, 53, 3611–17.

    Google Scholar 

  4. Niessen CM, Hogervorst F, Jaspers LH, et al. 1994, The alpha 6 beta 4 integrin is a receptor for both laminin and kalinin. Exp Cell Res, 211, 360–7.

    Google Scholar 

  5. Kemperman H, Wijnands Y, Meijne AML and Roos E, 1994, TA3/St, but not TA3/Ha, mammary carcinoma cell adhesion to hepatocytes is mediated by alpha 5 beta 1 interacting with surface-associated fibronectin. Cell Adhesion and Communication, 2, 45–58.

    Google Scholar 

  6. Middelkoop OP, van Bavel P, Calafat J and Roos E, 1985, Hepatocyte surface molecule involved in the adhesion of TA3 mammary carcinoma cells to rat hepatocyte cultures. Cancer Res, 45, 3825–35.

    Google Scholar 

  7. Hauschka TS, Weiss L, Holdridge BA, et al. 1971, Karyotypic and surface features of murine TA3 carcinoma cells during immunoselection in mice and rats. J Natl Cancer Inst, 47, 343–59.

    Google Scholar 

  8. Roos E, Middelkoop OP and Van de Pavert IV, 1984, Adhesion of tumor cells to hepatocytes: different mechanisms for mammary carcinoma compared with lymphosarcoma cells. J Natl Cancer Inst, 73, 963–9.

    Google Scholar 

  9. Roos E and Van de Pavert IV, 1982, Effect of tubulin-binding agents on the infiltration of tumour cells into primary hepatocyte cultures. J Cell Sci, 55, 233–45.

    Google Scholar 

  10. McConahey PJ and Dixon FJ, 1980, Radioiodination of proteins by the use of the chloramine-T method. Methods Enzymol, 70, 210–3.

    Google Scholar 

  11. Ray TK, 1970, A modified method for the isolation of the plasma membrane from rat liver. Biochim Biophys Acta, 196, 1–9.

    Google Scholar 

  12. Chung LP, Keshav S and Gordon S, 1988, Cloning the human lysozyme cDNA: inverted Alu repeat in the mRNA and in situ hybridization for macrophages and Paneth cells. Proc Natl Acad Sci USA, 85, 6227–31.

    Google Scholar 

  13. Kristensen T, Ogata RT, Chung LP, Reid KB and Tack BF, 1987, cDNA structure of murine C4b-binding protein, a regulatory component of the serum complement system. Biochemistry, 26, 4668–74.

    Google Scholar 

  14. Eggertsen G, Hudson G, Shiels B, Reed D and Fey GH, 1991, Sequence of rat alpha 1-macroglobulin, a broad-range proteinase inhibitor from the alphamacroglobulin complement family. Mol Biol Med, 8, 287–302.

    Google Scholar 

  15. Feizi T, 1985, Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigens. Nature, 314, 53–7.

    Google Scholar 

  16. Hakomori S, 1985, Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives. [Review]. Cancer Res, 45, 2405–14.

    Google Scholar 

  17. Gooi HC, Feizi T, Kapadia A, et al. 1981, Stage-specific ambryonic antigen involves α1 → α3 fucosylated type 2 blood group chains. Nature, 292, 156–8.

    Google Scholar 

  18. Gooi HC, Thorpe SJ, Hounsell EF, et al. 1983, Marker of peripheral blood granulocytes and monocytes of man recognized by two monoclonal antibodies VEP8 and VEP9 involves the trisaccharide 3-fucosyl-Nacetyllactosamine. Eur J Immunol, 13, 306–12.

    Google Scholar 

  19. True DD, Singer MS, Lasky LA and Rosen SD, 1990, Requirement for sialic acid on the endothelial ligand of a lymphocyte homing receptor. J Cell Biol, 111, 2757–64.

    Google Scholar 

  20. Varki A, 1992, Selectins and other mammalian sialic acid-binding lectins. [Review]. Curr Opin Cell Biol, 4, 257–66.

    Google Scholar 

  21. Dejana E, Martin-Padura I, Lauri D, et al. 1992, Endothelial leukocyte adhesion molecule-1-dependent adhesion of colon carcinoma cells to vascular endothelium is inhibited by an antibody to Lewis fucosylated type I carbohydrate chain. Lab Invest, 66, 324–30.

    Google Scholar 

  22. Oz OK, Campbell A and Tao TW, 1989, Reduced cell adhesion to fibronectin and laminin is associated with altered glycosylation of beta 1 integrins in a weakly metastatic glycosylation mutant. Int J Cancer, 44, 343–7.

    Google Scholar 

  23. Symington BE, Symington FW and Rohrschneider LR, 1989, Phorbol ester induces increased expression, altered glycosylation, and reduced adhesion of K562 erythroleukemia cells to fibronectin receptors. J Biol Chem, 264, 13258–66.

    Google Scholar 

  24. Akiyama SK, Yamada SS and Yamada KM, 1989, Analysis of the role of glycosylation of the human fibronectin receptor. J Biol Chem, 264, 18011–8.

    Google Scholar 

  25. Dean JW, Chandrasekaran S and Tanzer ML, 1990, A biological role of the carbohydrate moieties of laminin. J Biol Chem, 265, 12553–62.

    Google Scholar 

  26. Runyan RB, Versalovic J and Shur BD, 1988, Functionally distinct laminin receptors mediate cell adhesion and spreading: the requirement for surface galactosyltransferase in cell spreading. J Cell Biol, 107, 1863–71.

    Google Scholar 

  27. Stamatoglou SC and Hughes RC, 1994, Cell adhesion molecules in liver function and pattern formation. FASEB J, 8, 420–7.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kemperman, H., Wijnands, Y. & Roos, E. Adhesion of carcinoma cells to rat hepatocytes and rat fibronectin is inhibited by the OPAR monoclonal antibody, which is directed against a rat liver-specific carbohydrate epitope. Clin Exp Metast 13, 23–32 (1995). https://doi.org/10.1007/BF00144015

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00144015

Keywords

Navigation